🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of Parts A and B of this study is to evaluate the safet...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2010-02
Trial ID
NCT01115790
Treatments Being Tested
The main purpose of this study is to investigate the safety of prexasertib ...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2014-06-18
Trial ID
NCT02124148
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of prexase...
Status
Completed
Location
Highlands Oncology Group
Start Date
2016-05-11
Trial ID
NCT02735980
Treatments Being Tested
The main purpose of this study is to evaluate the safety of the study drug ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2016-09-22
Trial ID
NCT02778126
Treatments Being Tested
The primary purpose of this study is to assess the tolerability of prexaser...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2015-10
Trial ID
NCT02514603
Treatments Being Tested
This research study is studying a targeted therapy combined with chemothera...
Status
Terminated
Location
Dana Farber Cancer Institute
Start Date
2019-01-18
Trial ID
NCT03735446
Treatments Being Tested
The main purpose of this study is to evaluate the safety of the study drug ...
Status
Completed
Location
Carolinas Medical Center
Start Date
2016-08-10
Trial ID
NCT02860780
Treatments Being Tested
This phase I trial studies the side effects and best dose of prexasertib in...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-02-27
Trial ID
NCT02808650
Treatments Being Tested
This research study is studying a checkpoint kinase 1 (CHK1) inhibitor as a...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-12
Trial ID
NCT02873975
Treatments Being Tested
This study evaluates efficacy of LY3023414 and prexasertib in patients with...
Status
Completed
Location
Baylor University Medical Center
Start Date
2019-09-05
Trial ID
NCT04032080
Treatments Being Tested